Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Thibault Griseri has been awarded a Career Development Fellowship from Arthritis Research UK for his project on “Haematopoietic stem and progenitor cells as novel therapeutic targets in chronic inflammatory arthritis”.

Around 10 million people in the UK have arthritis and over 500,000 suffer from chronic inflammatory arthritis. There is yet no cure for this highly disabling and painful condition, although there are many available treatments, which help to slow down the condition. Understanding what causes the inflammation and the chronicity of some types of arthritis is key to the development of better treatments. By bringing together the fields of haematopoiesis – the formation of blood cellular components – and immunology, Dr Griseri’s project will look into how haematopoiesis inside and outside the bone marrow is influenced by inflammatory signals and how haematopoietic stem cells and progenitors cells contribute to chronicity of disease in inflammatory arthritis.

Speaking of his award, Dr Griseri says: "I am delighted and grateful to get this award because it will have a great impact in what is known about arthritis and we will be able to further develop our study of the regulation of haematopoiesis in intestinal inflammatory diseases1 to models of chronic inflammation arthritis and explore the possible crosstalk between intestinal and joint inflammation. Establishing this link will bring us closer to more advanced treatments for this condition."

Similar stories

Matthew Costa elected Fellow of Academy of Medical Sciences

Matthew Costa, Professor of Orthopaedic Trauma Surgery at NDORMS, has been elected a Fellow of the Academy of Medical Sciences.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

REF 2021 results for medical research in Oxford

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Nurses' Day 2022

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

Rethinking pain management after injury

NDORMS researchers are to study whether a pain management treatment using cognitive behavioural therapy will improve recovery for people who have had a major leg injury.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.